Background illustration for clinical trials search

Myasthenia Gravis Clinical Trials

Browse 1,513 myasthenia gravis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Active & Responsive

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

for
Rare Disorders, Undiagnosed Disorders,
Location: Sioux Falls SD
Sponsor: Sanford Health

Sex: All

Age: 0+

Code: NCT01793168

Recruiting
Active & Responsive

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

for
Myasthenia Gravis, Generalized Myasthenia Gravis
Location: Philadelphia PA, Miami FL, Indianapolis IN, Columbia MO,
Sponsor: Kyverna Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06193889

Phase 2, Phase 3, Recruiting
Active & Responsive

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

for
Generalized Myasthenia Gravis
Location: Boston MA, New Haven CT, New Hyde Park NY,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT04202341

Recruiting
Active & Responsive

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

for
Alpha-Thalassemia, Beta-Thalassemia, Amyloidosis,
Location: Los Altos CA
Sponsor: xCures

Sex: All

Age: 0+

Code: NCT06539169

Recruiting
Active & Responsive

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

for
Generalized Myasthenia Gravis
Location: Farmington CT, Burlington VT, Washington D.C. DC,
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Sex: All

Age: 18+

Code: NCT06463587

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

for
Myasthenia Gravis
Location: Lake Success NY, Philadelphia PA, Durham NC,
Sponsor: Ad scientiam

Sex: All

Age: 18+

Code: NCT05564936

Recruiting
Active & Responsive

Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)

for
Multiple Sclerosis, Clinically Isolated Syndrome, NMOSD,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: Female

Age: 18 - 64

Code: NCT06940323

Recruiting
Active & Responsive

Feasibility of Remote Monitoring of Patients With Myasthenia Gravis

for
Myasthenia Gravis (MG)
Location: Washington D.C. DC
Sponsor: George Washington University

Sex: All

Age: 18+

Code: NCT07787247

Recruiting
Active & Responsive

A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

for
Myasthenia Gravis
Location: Boca Raton FL, Altamonte Springs FL, Naples FL,
Sponsor: ImmunAbs Inc.

Sex: All

Age: 18 - 70+

Code: NCT07250750

Phase 1, Phase 2, Recruiting
Active & Responsive

Vitaccess Real MG Registry

for
Myasthenia Gravis
Location: Lumberton NJ, Charleston SC, Lexington KY, O'Fallon IL,
Sponsor: Vitaccess Ltd

Sex: All

Age: 18+

Code: NCT06064461

Recruiting
Active & Responsive

Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

for
Myasthenia Gravis, Myasthenia Gravis, MuSK
Location: Chapel Hill NC, Boca Raton FL, Tampa FL, Augusta GA,
Sponsor: NMD Pharma A/S

Sex: All

Age: 18+

Code: NCT06414954

Phase 2, Recruiting
Active & Responsive

The Neurodevelopmental and Behavioral Phenotyping Screening Protocol

for
Neurologic Disorders, Autism, Neurodegenerative Disease,
Location: Bethesda MD
Sponsor: National Institute of Mental Health (NIMH)

Sex: All

Age: 0+

Code: NCT00271622

Recruiting
Active & Responsive

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

for
Autoimmune Disease, Crohn Disease, Dermatomyositis,
Location: Boston MA, New Haven CT, Mineola NY, New York NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03816345

Phase 1, Recruiting
Active & Responsive

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Genital Neoplasm, Female,
Location: Boston MA, Bethesda MD, Toronto, Celebration FL,
Sponsor: Marengo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05592626

Phase 1, Phase 2, Recruiting
Active & ResponsiveNew

This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic Colorectal Cancer and Other Solid Tumors

for
Colorectal Cancer, Advanced/Metastatic Solid Tumor,
Location: Scottsdale AZ
Sponsor: LTZ Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07878988

Phase 1, Recruiting
Active & ResponsiveNew

Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease

for
Thyroid Eye Disease (TED), Graves' Disease,
Location: Wilmington NC, Orland Park IL
Sponsor: Ethyreal Bio, Inc.

Sex: All

Age: 18+

Code: NCT07885605

Phase 1, Recruiting
Active & Responsive

FOG-001 in Locally Advanced or Metastatic Solid Tumors

for
Cancer, Colorectal Cancer, Solid Tumor,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Parabilis Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05919264

Phase 1, Phase 2, Recruiting
Active & Responsive

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

for
Breast Neoplasms, Brain Neoplasms, Neoplasms by Site, Neoplasms,
Location: Boston MA, Norfolk VA, Detroit MI, Centerville OH,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05386108

Phase 1, Phase 2, Recruiting
Active & Responsive

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

for
Diabetes Mellitus, Type 1, Hypoglycemia,
Location: Chicago IL
Sponsor: Otsuka Pharmaceutical Factory, Inc.

Sex: All

Age: 35 - 70

Code: NCT06575426

Phase 1, Phase 2, Recruiting
Active & Responsive

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

for
Parkinson Disease, Prodromal Stage, Neurodegenerative Diseases,
Location: Rochester NY
Sponsor: Radboud University Medical Center

Sex: All

Age: 50+

Code: NCT06993142

Recruiting